Key Points
- Liquidia director Katherine Rielly-Gauvin sold 36,789 shares at an average price of $74.99, generating $2.76 million. The Rule 10b5-1 transaction reduced her direct holdings by 45.18% to 44,637 shares; she also sold 18,393 shares for $1.33 million the following day.
- Liquidia reported quarterly revenue of $171.68 million, up 1,842.1% year over year, though adjusted earnings of $0.74 per share narrowly missed analysts’ $0.76 estimate.
- Analyst sentiment is mixed, with a consensus rating of “Hold” and an average price target of $98.08. The stock opened at $68.62 and has traded between $21.15 and $93.61 over the past year.
Liquidia Corporation (NASDAQ:LQDA - Get Free Report) Director Katherine Rielly-Gauvin sold 18,393 shares of the firm's stock in a transaction dated Thursday, August 20th. The stock was sold at an average price of $72.23, for a total transaction of $1,328,526.39. Following the completion of the sale, the director directly owned 44,637 shares of the company's stock, valued at approximately $3,224,130.51. The trade was a 29.18% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Katherine Rielly-Gauvin also recently made the following trade(s):
- On Wednesday, August 19th, Katherine Rielly-Gauvin sold 36,789 shares of Liquidia stock. The shares were sold at an average price of $74.99, for a total value of $2,758,807.11.
Liquidia Price Performance
Liquidia stock opened at $68.62 on Friday. Liquidia Corporation has a 1 year low of $21.15 and a 1 year high of $93.61. The stock has a market cap of $6.14 billion, a price-to-earnings ratio of 50.09 and a beta of 0.58. The firm has a 50-day moving average of $79.29 and a two-hundred day moving average of $56.21. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.31 and a quick ratio of 2.12.
Liquidia (NASDAQ:LQDA - Get Free Report) last released its quarterly earnings data on Wednesday, August 12th. The company reported $0.74 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.76 by ($0.02). Liquidia had a net margin of 30.74% and a return on equity of 149.65%. The business had revenue of $171.68 million for the quarter, compared to the consensus estimate of $168.48 million. During the same quarter in the prior year, the business posted ($0.49) earnings per share. Liquidia's revenue for the quarter was up 1842.1% on a year-over-year basis. On average, research analysts forecast that Liquidia Corporation will post 2.57 earnings per share for the current year.
Analysts Set New Price Targets
LQDA has been the topic of several research analyst reports. HC Wainwright set a $36.00 target price on shares of Liquidia in a research report on Friday, July 24th. Stephens set a $130.00 price objective on shares of Liquidia in a research note on Friday, July 24th. Jefferies Financial Group reiterated a "buy" rating and set a $60.00 price target on shares of Liquidia in a research report on Monday, May 11th. Weiss Ratings reiterated a "sell (d-)" rating on shares of Liquidia in a research report on Friday, July 17th. Finally, Royal Bank Of Canada set a $130.00 target price on Liquidia in a research report on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, three have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $98.08.
View Our Latest Report on Liquidia
Institutional Investors Weigh In On Liquidia
Several institutional investors and hedge funds have recently added to or reduced their stakes in LQDA. Northwestern Mutual Wealth Management Co. purchased a new stake in shares of Liquidia during the fourth quarter worth $25,000. NewEdge Advisors LLC purchased a new position in shares of Liquidia in the second quarter worth about $25,000. Covestor Ltd boosted its position in Liquidia by 41.9% during the fourth quarter. Covestor Ltd now owns 1,216 shares of the company's stock worth $42,000 after acquiring an additional 359 shares during the last quarter. Tower Research Capital LLC TRC grew its stake in Liquidia by 281.2% during the 2nd quarter. Tower Research Capital LLC TRC now owns 6,679 shares of the company's stock valued at $83,000 after acquiring an additional 4,927 shares in the last quarter. Finally, Globeflex Capital L P acquired a new stake in Liquidia in the 2nd quarter valued at about $175,000. Institutional investors and hedge funds own 64.54% of the company's stock.
About Liquidia
(
Get Free Report)
Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.
The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
